June 23, 2008 -- At the recent 2008 BIO Convention, a panel of industry experts discussed their experience with making biomedical investments in China. The title of the sessions was: Building a ‘Life Sciences Bridge’: Opportunities and Challenges in Venture Capital Investment in Asia. Many topics surfaced, including a discussion of the beneficial effects that big pharma will have on the China talent pool. More details...
